The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an
index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
ISHARES BTEK Stock | London Stock Exchange
FromToTotal ReturnThis is an input box to enter up to four benchmarks that you want to compare with the base ric.Use left and right arrow keys to navigate, enter to create, delete to delete tags Only list items can be added as tagsThis is an input box to enter up to ten indicators.Use left and right arrow keys to navigate, enter to create, delete to delete tags Use up and down arrow keys to navigate list items and enter to add a new tag Only list items can be added as tags
Top holdings, as of 30 November 2025
| Rank | Name | % Weight |
|---|---|---|
| 1 | AMGEN INC ORD | 7.80 |
| 2 | GILEAD SCIENCES INC ORD | 7.24 |
| 3 | VERTEX PHARMACEUTICALS INC ORD | 7.20 |
| 4 | REGENERON PHARMACEUTICALS INC ORD | 6.33 |
| 5 | ALNYLAM PHARMACEUTICALS INC ORD | 4.61 |
| 6 | ASTRAZENECA ADR REP 0.5 ORD | 3.77 |
| 7 | INSMED INC ORD | 3.45 |
| 8 | ARGENX ADR REP ORD | 2.19 |
| 9 | BIOGEN INC ORD | 2.10 |
| 10 | UNITED THERAPEUTICS CORP ORD | 1.73 |
Courtesy of the London Stock Exchange
Net Assets of Fund (M) : 859.37 Million USD
Courtesy of the London Stock Exchange
